|
RNPS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.027900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.34499999999849E-05 |
| Normal-vs-Stage2 |
4.444200E-01 |
| Normal-vs-Stage3 |
1.672310E-02 |
| Normal-vs-Stage4 |
4.802800E-04 |
| Stage1-vs-Stage2 |
2.271600E-02 |
| Stage1-vs-Stage3 |
2.052000E-01 |
| Stage1-vs-Stage4 |
6.480200E-01 |
| Stage2-vs-Stage3 |
2.304400E-01 |
| Stage2-vs-Stage4 |
2.223700E-02 |
| Stage3-vs-Stage4 |
1.668160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.177300E-03 |
| Normal-vs-AfricanAmerican |
1.40629999867414E-08 |
| Normal-vs-Asian |
4.700900E-03 |
| Caucasian-vs-AfricanAmerican |
1.37270000033496E-07 |
| Caucasian-vs-Asian |
1.077840E-01 |
| AfricanAmerican-vs-Asian |
6.764200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.182500E-03 |
| Normal-vs-Female |
2.07399999999636E-05 |
| Male-vs-Female |
1.019960E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.836100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.407500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.458260E-03 |
| Normal-vs-Age(81-100Yrs) |
9.755400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.949000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.027000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.332400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.871200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.624300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.357700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.6951999999868E-06 |
| Normal-vs-Grade 2 |
5.008400E-04 |
| Normal-vs-Grade 3 |
1.452270E-02 |
| Normal-vs-Grade 4 |
5.202600E-04 |
| Grade 1-vs-Grade 2 |
9.797500E-03 |
| Grade 1-vs-Grade 3 |
2.619000E-03 |
| Grade 1-vs-Grade 4 |
5.292400E-02 |
| Grade 2-vs-Grade 3 |
2.043800E-01 |
| Grade 2-vs-Grade 4 |
3.276600E-01 |
| Grade 3-vs-Grade 4 |
6.350100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.080090E-02 |
| Normal-vs-ccB subtype |
4.637100E-03 |
| ccA subtype-vs-ccB subtype |
5.373600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.183900E-03 |
| Normal-vs-N1 |
1.134220E-02 |
| N0-vs-N1 |
3.074400E-02 |
|
|
